# Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

> **NCT02472717** · PHASE2 · WITHDRAWN · sponsor: **University Health Network, Toronto**

## Conditions studied

- Psoriatic Arthritis
- Psoriasis
- Impaired Glucose Tolerance
- Type 2 Diabetes

## Interventions

- **DRUG:** liraglutide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02472717
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472717, "Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02472717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*